Press Releases

Varian to Host Investor Meeting at ASTRO in Chicago

Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,...

Varian Announces Immaterial Impact of Newly Proposed Tariffs

Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the...

Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning

Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse™ treatment planning software and ARIA® oncology information system to three radiotherapy...

Karolinska University Hospital Solna Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

Varian (NYSE: VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new...

Varian Reports Results for Third Quarter of Fiscal Year 2019

Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in dollars, or 13% in constant currency Total...

Varian to Showcase Cancer Care Systems and Software at AAPM 2019

Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY™ Guidance System, at the American Association of Physicists...

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June...

Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria

Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy...

Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset

Varian (NYSE: VAR) today announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of microsphere and bland embolic bead products for treating...

Varian Announces Third Quarter Fiscal Year 2019 Earnings Release Date

Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date. The Company will report results for the third quarter of fiscal year 2019 after market close on...